Posted on 10/12/2020 5:32:45 PM PDT by yesthatjallen
.... and the newly formed Biotech Industry will need another 50 billion to study the latest “virus”
I never gave the idea of a vaccine any credibility.
There has never been a successful vaccine for a Corona virus in the past due to the rapid mutation of this kind of virus.
By the time you can bring a vaccine to market the virus has moved on.
Which is why the use of drugs like HCQ is a much better strategy. They work by preventing the replication of the virus inside the cell.
Never thought I would miss good ‘ol terrorism , now that was a benign boogeyman compared to this load of crap
I went to school with a girl who has the chicken pox twice...
It happens.
But let the chicken littles scream.
Twice!
Im beginning to think that there is no such virus.
What is truly remarkable about this 1st confirmed case of reinfection is that it is the 20th 1st confirmed case of reinfection, the 21st case will also be the 1st, and even then still there will be no actual first cases.
1 person out of 300,000,000.
Probably a test error.
Statistically insignificant.
Everybody, panic!
That’s what I don’t get. How is it a true reinfection if it’s 2 different strains? Also, if you read further into the article, then they tell you how rare this is. They also never say anything about this person’s health. Is he someone with a compromised immune system?
Panic, everybody panic.
Dang, that lessens my chances of being shot by a jealous husband when I’m 101.
In April, how many friggin’ false positive tests were there from the contaminated CDC test kits?
I call Bull on this “second infection.” The first was a false positive, and the “second” was a genuine infection.
“How many strains are there? I wish the experts would give US those details”
I think I saw 6 different strains.
People are still giving them credence after having to retract an article on a bogus hydroxychloroquine study?
June 4, 2020 - The online medical journal The Lancet has apologized to readers after retracting a study that said the anti-malarial drug hydroxychloroquine did not help to curb COVID-19 and might cause death in patients.
The study was withdrawn because the company that provided data would not provide full access to the information for a third-party peer review, saying to do so would violate client agreements and confidentiality requirements, The Lancet said in a statement.
A reputable journal would have required that before ever publishing the study in the first place.
Currently, there are six strains of coronavirus. The original one is the L strain, that appeared in Wuhan in December 2019. Its first mutation — the S strain — appeared at the beginning of 2020, while, since mid-January 2020, we have had strains V and G. To date strain G is the most widespread: it mutated into strains GR and GH at the end of February 2020.
“Strain G and its related strains GR and GH are by far the most widespread, representing 74% of all gene sequences we analysed,” says Giorgi. “They present four mutations, two of which are able to change the sequence of the RNA polymerase and Spike proteins of the virus. This characteristic probably facilitates the spread of the virus.”
If we look at the coronavirus map, we can see that strains G and GR are the most frequent across Europe and Italy. According to the available data, GH strain seems close to non-existence in Italy, while it occurs more frequently in France and Germany. This seems to confirm the effectiveness of last months’ containment methods.
In North America, the most widespread strain is GH, while in South America we find the GR strain more frequently. In Asia, where the Wuhan L strain initially appeared, the spread of strains G, GH and GR is increasing. These strains landed in Asia only at the beginning of March, more than a month after their spread in Europe.
Globally, strains G, GH and GR are constantly increasing. Strain S can be found in some restricted areas in the US and Spain. The L and V strains are gradually disappearing.
Besides these six main coronavirus strains, researchers identified some infrequent mutations, that, at the moment, are not worrying but should nevertheless be monitored.
“Rare genomic mutations are less than 1% of all sequenced genomes,” confirms Giorgi. “However, it is fundamental that we study and analyse them so that we can identify their function and monitor their spread. All countries should contribute to the cause by giving access to data about the virus genome sequences.”
This study was published in the journal Frontiers in Microbiology with the title “Geographic and Genomic Distribution of SARS-CoV-2 Mutations.” The authors are Daniele Mercatelli and Federico M. Giorgi, both from the Department of Pharmacy and Biotechnology of the University of Bologna.
Well, I am no expert, and do not pretend to be one.. but, I do question things said and written.. how can there be an universal vaccine if there are multiple strains.
My likely theory on this is that the 25 year old received a false positive the first time, and the “second time” was really his first time.
If it was two different strains, can it be considered a RE-infection? Is there a doctor in the house?
Read the article.
They all have spikes. The vaccine must attack the common element.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.